The relationship between mean platelet volume with metabolic syndrome in obese individuals

Kutlucan A., BULUR S., Kır S., Bulur Ş., Önder E., Aslantaş Y., ...More

BLOOD COAGULATION & FIBRINOLYSIS, vol.23, no.5, pp.388-390, 2012 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 5
  • Publication Date: 2012
  • Doi Number: 10.1097/mbc.0b013e328352e8fa
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.388-390
  • Keywords: means platelet volume, metabolic syndrome, obesity, SIZE, DETERMINANTS, RISK


The metabolic syndrome is closely associated with atherosclerotic risk factors and increased mortality. Mean platelet volume (MPV) is an indicator of platelet activation which also shows a close relationship with cardiovascular risk factors, such as diabetes mellitus, hypertension, hypercholesterolemia, obesity, metabolic syndrome. The aim of this study was to investigate the correlates of metabolic syndrome, its components and MPV adjusted for obesity in a large population study. A total of 2298 individuals with a mean age of 50 (age range 18-92) were interviewed. Nine hundred and twenty obese participants, who had BMI 30 kg/m(2) or more, further evaluated for the presence of metabolic syndrome. Five hundred and thirteen [396 women (70.2%)] had metabolic syndrome and the rest 407 individuals [324 women (79.6%)] served as the control group. The BMI, SBP, DBP, waist circumference, fasting plasma glucose, visceral fat, total cholesterol, high-density lipoprotein-cholesterol, and triglyceride was higher significantly in metabolic syndrome group (P=0.002 for BMI and P<0.001 for the others). No significant difference was observed between groups regarding low-density lipoprotein cholesterol, white blood cells, platelet counts, MPV, hematocrit and hemoglobin (P>0.05 for all). The presence of metabolic syndrome and its components do not constitute a difference in MPV values in obese patients with a BMI 30 kg/m(2) or more. Blood Coagul Fibrinolysis 23:388-390 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.